EHA , Lithuania , Albania Share this item Prof. Dominik Wolf, MD from the Medical University Innsbruck, Innsbruck, Austria is talking about data on teal world experience with tisagenlecleucel presented at EHA 2019 in Amsterdam
EHA 2019 Srdan Verstovsek, MD, PhD - educational session MPN Srdan Verstovsek, MD, PhD from the MD Anderson Center, Houston, USA is commenting on the educational session on MPN, which took place during EHA 2019 in Amsterdam EHA , Countries , Latvia , Lithuania , Estonia , Albania 00:05:41
EHA 2019 Jeroen Janssen, MD, PhD Jeroen Janssen MD, PhD from the Amsterdam UMC, Amsterdam, The Netherlands is commenting on the abstract COMBINATION THERAPY USING ASCIMINIB PLUS IMATINIB (IMA) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML) & COMBINATION OF ASCIMINIB PLUS NILOTINIB (NIL) OR DASATINIB (DAS) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA Reference: EHA Library. Kew S. Jun 15, 2019; 267467Link to abstract: https://library.ehaweb.org/eha/2019/24th/267467/sam.kew.combination.of.asciminib.plus.nilotinib.28nil29.or.dasatinib.28das29.in.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dasciminib EHA , Latvia , Lithuania , Estonia , Albania 00:05:04
EHA 2019 Prof. Michael Pfeilstöcker, MD Prof. Michael Pfeilstöcker, MD from the Heinrich-Heine University Hospital, Düsseldorf, Germany is commenting on 2 publications LONG-TERM OVERUSE OF CORTICOSTEROIDS IN THE REAL-WORLD TREATMENT OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA IN THE US EXPLORYS AND MARKETSCAN DATABASES Reference: EHA Library. Bussel J. Jun 14, 2019; 266509Link to abstract: https://library.ehaweb.org/eha/2019/24th/266509/j.bussel.long-term.overuse.of.corticosteroids.in.the.real-world.treatment.of.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DLONG-TERM+OVERUSE+OF+CORTICOSTEROIDS+IN+THE+REAL-WORLD+TREATMENT+OF+PATIENTS+WITH+IMMUNE+THROMBOCYTOPENIA+IN+THE+US+EXPLORYS+AND+MARKETSCAN+DATABASESDIFFERENCES IN PERCEPTIONS ON TREATMENT APPROACHES BETWEEN PHYSICIANS AND ITP PATIENTS: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH) both presented at EHA 2019 in AmsterdamReference: EHA Library. Kruse A. Jun 14, 2019; 266510Link to abstract: https://library.ehaweb.org/eha/2019/24th/266510/alexandra.kruse.differences.in.perceptions.on.treatment.approaches.between.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dresults%2Bitp+world+impact+survey+%28i-wish EHA , Latvia , Lithuania , Estonia , Albania 00:05:30
EHA 2019 Francesco Rodeghiero, MD, PhD Francesco Rodeghiero, MD, PhD from the San Bartolo Hospital Vicenza, Italy is commenting on his ITP highlights presented at EHA 2019 in Amsterdam EHA , Latvia , Lithuania , Estonia , Albania 00:06:10
ESMO 2019 Valentina Guarneri, MD, PhD; Overall survival (OS) results of the Phase III MONALEESA-3 trial Valentina Guarneri, MD, PhD from the University of Padua, Padua, Italy is commenting on the abstract: LBA7_PR - Overall survival (OS) results of the Phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2−) advanced breast cancer (ABC) treated with fulvestrant (FUL) ± ribociclib (RIB) ESMO , Kisqali Channel , Latvia , Lithuania , Estonia , Hungary , Albania 00:03:29
EHA 2019 Ruben Mesa, MD, FACP Ruben Mesa, MD, FACP from the UT Health San Antonio MD Anderson, San Antonio, USA is commenting on BODY MASS INDEX AND TOTAL SYMPTOM BURDEN IN MYELOPROLIFERATIVE NEOPLASMS - DISCOVERY OF A U-SHAPED ASSOCIATION, which was presented at EHA 2019 in AmsterdamReference: EHA Library. Scheber R. Jun 14, 2019; 266475https://library.ehaweb.org/eha/2019/24th/266475/robyn.scheber.body.mass.index.and.total.symptom.burden.in.myeloproliferative.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DBODY+MASS+INDEX+AND+TOTAL+SYMPTOM+BURDEN+IN+MYELOPROLIFERATIVE+NEOPLASMS+-+DISCOVERY+OF+A+U-SHAPED+ASSOCIATION EHA , Lithuania , Hungary , Albania 00:04:45
